Financial Statements · Financial Reporting
AS Bravo Pharmaceuticals
Official identifier 14159974Record date 31 Dec 2019
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2019
- Period start
- 1 Jan 2019
- Submitted date
- 21 Sep 2021
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 166,903 |
| Balance sheet | Cash and cash equivalents | 1,213 |
| Balance sheet | Current assets | 96,961 |
| Balance sheet | Current liabilities | 8,554 |
| Balance sheet | Equity | 118,307 |
| Balance sheet | Share capital at nominal value | 50,000 |
| Balance sheet | Non-current assets | 69,942 |
| Balance sheet | Non-current liabilities | 40,042 |
| Balance sheet | Retained earnings (loss) from previous periods | 89,666 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -1,296 |
| Income statement scheme 1 | Labour costs | -24,189 |
| Income statement scheme 1 | Revenue | 22,429 |
| Income statement scheme 1 | Annual period profit / loss | -24,959 |
| Income statement scheme 1 | Operating profit (loss) | -24,947 |
| Income statement scheme 1 | Profit (loss) before income tax | -24,959 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 89,666 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 24,189 |
Linked company
Company: AS Bravo Pharmaceuticals